Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci

被引：44
作者：
Hardy, D
Amsterdam, D
Mandell, LA
Rotstein, C
机构：
[1] McMaster Univ, Hamilton Hlth Sci Cor, McMaster Med Unit, Div Infect Dis, Hamilton, ON L8V 1C3, Canada
[2] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA
[3] Univ Buffalo, Dept Microbiol Med & Pathol, Sch Med, Buffalo, NY USA
[4] Erie Cty Med Ctr & Labs, Buffalo, NY 14215 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2000年 / 44卷 / 03期
关键词：
D O I：
10.1128/AAC.44.3.802-805.2000
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The in vitro activity of gemifloxacin against 316 bloodstream isolates of staphylococci, pneumococci, and enterococci was compared with the activities of six fluoroquinolones and three other antimicrobial agents. Of the antimicrobial agents tested, gemifloxacin was the most potent against penicillin-intermediate and -resistant pneumococci, methicillin-susceptible and -resistant Staphylococcus epidermidis isolates, and coagulase-negative staphylococci.
引用
收藏
页码：802 / 805
页数：4
相关论文
共 10 条
  • [1] [Anonymous], 1999, M100S9 NAT COMM CLIN
  • [2] Community-acquired pneumonia in adults: Guidelines for management
    Bartlett, JG
    Breiman, RF
    Mandell, LA
    File, TM
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) : 811 - 838
  • [3] EMERGENCE AND NOSOCOMIAL TRANSMISSION OF AMPICILLIN-RESISTANT ENTEROCOCCI
    BOYCE, JM
    OPAL, SM
    POTTERBYNOE, G
    LAFORGE, RG
    ZERVOS, MJ
    FURTADO, G
    VICTOR, G
    MEDEIROS, AA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) : 1032 - 1039
  • [4] *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P297
  • [5] Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone
    Cormican, MG
    Jones, RN
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) : 204 - 211
  • [6] Davidson R J, 1999, Can J Infect Dis, V10, P128
  • [7] Vancomycin-resistant enterococci - Mechanism and clinical relevance
    Eliopoulos, GM
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1997, 11 (04) : 851 - &
  • [8] Antimicrobial resistance in staphylococci - Epidemiology, molecular mechanisms, and clinical relevance
    Maranan, MC
    Moreira, B
    BoyleVavra, S
    Daum, RS
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1997, 11 (04) : 813 - +
  • [9] *NAT COMM CLIN LAB, 1997, M7A4 NAT COMM CLIN L
  • [10] Emergence of vancomycin resistance in Staphylococcus aureus
    Smith, TL
    Pearson, ML
    Wilcox, KR
    Cruz, C
    Lancaster, MV
    Robinson-Dunn, B
    Tenover, FC
    Zervos, MJ
    Band, JD
    White, E
    Jarvis, WR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (07) : 493 - 501
1